Integrative methylation and miRNA dysregulation in dlPFC reveal distinct molecular signatures of suicide and non‐suicide subtypes in major depressive disorder
Psychiatry and Clinical Neurosciences · 2026-09 · 80 (9) · 757-764
DOI: 10.1111/pcn.70090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychiatry and Clinical Neurosciences, online erschienen am 28.05.2026. Verfasst von Aleena Francis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Neurobiology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Major Depressive Disorder, MicroRNAs, DNA Methylation, Suicide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIMH NIH HHS, National Institute of Mental Health.
Abstract (Originalsprache)
Aim
Major depressive disorder (MDD) is a leading cause of disability and carries a high risk of suicide. MicroRNAs (miRNAs) are epigenetic regulators implicated in MDD and can be regulated by DNA methylation, potentially reshaping downstream gene networks. We investigated methylation‐linked miRNA dysregulation and explored whether these changes are specifically associated with suicide among MDD patients.
Methods
Genome‐wide DNA methylation profiling of the dorsolateral prefrontal cortex from 15 MDD patients who died by suicide (MDD+S), 17 MDD patients who died from causes other than suicide (MDD−S), and 16 controls (C) using the Illumina 850K MethylationEPIC array was integrated with small RNA sequencing‐based miRNA quantification to identify miRNA‐associated differentially methylated probes (DMPs), link methylation to miRNA expression, and infer downstream targets and pathways.
Results
Differential methylation analysis ( P ≤ 0.05) revealed 139 miRNA‐linked DMPs in C vs. MDD+/−S, 135 in C vs. MDD−S, 179 in C vs. MDD+S, and the highest in MDD+S vs. MDD−S (235). CpG‐miRNA pairing (within 1500kb promoter) followed by Spearman correlation identified inverse associations between CpG β values and miRNA expression, with the most consistent signals in suicide‐status‐stratified subsets, including cg06341821‐hsa‐miR‐574‐3p and cg25451306‐hsa‐miR‐2110 in MDD+S‐related contrasts, and cg06179179‐hsa‐miR‐595 in MDD−S‐related contrasts. High‐confidence target prediction and ClueGO enrichment indicated distinct biology: miR‐595 target genes in MDD−S were enriched for interferon/innate immune signaling, whereas miR‐2110 target genes in MDD+S were enriched for ligand‐gated ion channel activity and synaptic/receptor signaling.
Conclusion
This integrated approach identifies methylation‐regulated miRNA pathways that may play key roles in the molecular pathogenesis of MDD and suicide.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Neurobiology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
ORCID-Profile: Yogesh Dwivedi
Förderung
- NIMH NIH HHS
- National Institute of Mental Health
Zitieren
APA
Francis, A., & Dwivedi, Y. (2026). Integrative methylation and miRNA dysregulation in dlPFC reveal distinct molecular signatures of suicide and non‐suicide subtypes in major depressive disorder. Psychiatry and Clinical Neurosciences, 80(9), 757-764. https://doi.org/10.1111/pcn.70090
Vancouver
Francis A, Dwivedi Y. Integrative methylation and miRNA dysregulation in dlPFC reveal distinct molecular signatures of suicide and non‐suicide subtypes in major depressive disorder. Psychiatry and Clinical Neurosciences. 2026;80(9):757-764. doi:10.1111/pcn.70090
BibTeX
@article{Francis2026,
author = {Francis, Aleena and Dwivedi, Yogesh},
title = {Integrative methylation and miRNA dysregulation in dlPFC reveal distinct molecular signatures of suicide and non‐suicide subtypes in major depressive disorder},
journal = {Psychiatry and Clinical Neurosciences},
year = {2026},
volume = {80},
number = {9},
pages = {757--764},
doi = {10.1111/pcn.70090}
}
EUVIMED